Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 72

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 3
Chunk 72
---
 period
of time after filing or until issuance, we cannot be certain that we were the first to either (i) file any patent application related
to our product candidates and other proprietary technologies we may develop or (ii) invent any of the inventions claimed in our or our
licensor’s patents or patent applications. Even where we have a valid and enforceable patent, we may not be able to exclude others
from practicing the claimed invention where the other party can show that they used the invention in commerce before our filing date or
the other party benefits from a compulsory license. However, the Leahy-Smith Act and its implementation could increase the uncertainties
and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could
have a material adverse effect on our business, financial condition, results of operations and prospects.

Moreover, recent U. S. Supreme
Court rulings have narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners
in certain situations. In addition to increasing uncertainty with regard to our ability to obtain patents in the future, this combination
of events has created uncertainty with respect to the value of patents, once obtained. Depending on decisions by the U. S. Congress, the
federal courts, and the USPTO, the laws and regulations governing patents could change in unpredictable ways that would weaken our ability
to obtain new patents or to enforce our existing patents and patents that we might obtain in the future. We cannot predict how future
decisions by the courts, Congress or the USPTO may impact the value of our patents. Changes in the laws and regulations governing patents
in other jurisdictions could similarly have an adverse effect on our ability to obtain and effectively enforce our patent rights.

We may not be able to protect our intellectual
property rights throughout the world, and different jurisdictions may grant patent rights of differing scope.

Certain of our key patent
families have been filed in the United States; however, we have less robust intellectual property rights outside the United States, and,
in particular, we may not be able to pursue patent coverage of our product candidates in certain countries outside of the United States.
Filing, prosecuting and defending patents on product candidates in all countries throughout the world would be prohibitively expensive,
and our intellectual property rights in some countries outside the United States may be less extensive than those in the United States.
In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as federal and state